SCHEMBL7980265

SCHEMBL7980265

O=C(Nc1oc(-c2cccc(-c3ccc(-c4ccc5ccccc5c4)cc3)c2O)nc1-c1cccnc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 9/20 0.52
KDR P35968 5/20 0.45
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
HDAC1 Q13547 2/20 0.44
ABCB1 P08183 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
NAMPT P43490 1/20 0.41
HDAC3 O15379 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982616 0.89 KDR (0.56) SIRT2KDRFLT1FLT4NPC1
SCHEMBL7980188 0.87 NTRK1 (0.48) ABCB1NPC1MEN1ALDH1A1KMT2A
SCHEMBL7744167 0.85 HDAC1 (0.53) SIRT2KDRFLT1FLT4HDAC1
SCHEMBL7969453 0.84 HPGD (0.46) SIRT2KDRFLT1FLT4RAB9A
SCHEMBL7744170 0.82 F2 (0.45) KDRFLT1FLT4HDAC1ABCB1
SCHEMBL7744075 0.78 MAPT (0.53) HDAC1ABCB1RAB9AMEN1ALDH1A1
SCHEMBL7979621 0.77 KDR (0.50) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7980184 0.77 S1PR1 (0.45) KDRFLT1FLT4HDAC1ABCB1
SCHEMBL7983601 0.76 KDR (0.53) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7980821 0.76 KDR (0.54) KDRFLT1FLT4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed